Login
$MBOT
$1.12 +$0.09 (8.74%) Close

$MBOT 3 SEC Filings

Filed On Filing
16 Jan 2025 Form 3: Wilson David James, Director

No securities owned

01 Dec 2023 Form 3: Diaz-Cartelle Juan, Chief Medical Officer
15 Apr 2022 Form 3: Vaknin Rachel, Chief Financial Officer
07 Apr 2021 Form 3: Sharon Simon, General Manager & CTO
09 Sep 2020 Form 3: Wenderow Tal Baruch, Director

No securities owned

07 May 2020 Form 3: Morag Eyal, Chief Medical Officer

No securities owned

01 Apr 2020 Form 3: Stockburger Aileen Ptucha, Director

No securities owned

18 Oct 2019 Form 3: Mona Joseph, 10% owner

Holds 300,320 shares of Microbot Medical Common Stock

14 Dec 2017 Form 3: Laxminarain Prattipati, Director
07 Feb 2017 Form 3: Madden Martin J., Director

No securities owned

13 Dec 2016 Form 3: Naim David Ben, Chief Financial Officer

No securities owned

07 Dec 2016 Form 3: Himelfarb Yehezkel, General Manager & COO

No securities owned

05 Dec 2016 Form 3: Lewkowicz Leon, 10% owner

Holds 3,149,438 shares of Common Stock, par value $0.01 per share

30 Nov 2016 Form 3: Solomon Mayer, Director

No securities owned

30 Nov 2016 Form 3: Gadot Harel, Director

Holds 2,652,704 shares of Common Stock, par value $0.01 per share

30 Nov 2016 Form 3: Shoham Moshe, Director

Holds 1,842,090 shares of Common Stock, par value $0.01 per share

30 Nov 2016 Form 3: Berkson Avram, 10% owner and 1 other

Holds 4,307,003 shares of Common Stock, par value $0.01 per share

30 Nov 2016 Form 3: Burell Scott R, Director

No securities owned

30 Nov 2016 Form 3: Bornstein Yoseph, Director

Holds 5,305,409 shares of Common Stock, par value $0.01 per share

30 Nov 2016 Form 3: Waizer Yoav Zvi, Director

No securities owned

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support